Department of Bioengineering and Therapeutic Sciences

Guglielmo named interim dean of UCSF School of Pharmacy

Joseph Guglielmo, PharmD, has been named interim dean of the UCSF School of Pharmacy, and will take the reins of the school from outgoing Dean Mary Anne Koda-Kimble, PharmD

Nelson honored with Outstanding Faculty Mentorship Award

Sarah Nelson, PhD, was selected by the UCSF Graduate Students Association and Graduate Division Alumni Association as the winner of the 2012 Outstanding Faculty Mentorship Award.

Koda-Kimble is honored by UCSF Medical Center

Mary Anne Koda-Kimble, PharmD, dean of the UCSF School of Pharmacy, was honored by the UCSF Medical Center on May 4, 2012 for her “exceptional vision as a leader, commitment to patients, compassion as a human being, an

Remembering Harry W. Hind - pharmacist, inventor, leader, benefactor

Harry W. Hind, a 1939 graduate of the UCSF School of Pharmacy who invented solutions that revolutionized contact lens use, as well as a topical patch to treat pain from shingles, died on April 12 at age 96.

Artificial kidney project led by Roy cited at White House panel

Speaking on a White House panel discussing President Obama's just-released Bioeconomy Blueprint, UCSF Vice Chancellor for Research Keith Yamamoto, PhD, cited the implantable bioartificial kidney project led by UCSF b

New NIH funding awarded to the Department of Bioengineering and Therapeutic Sciences in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included a half-dozen on-going projects by BTS faculty:

UCSF School of Pharmacy’s 32nd year of top NIH funding includes many new projects

For the 32nd consecutive year, the UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

Desai receives Dawson Biotechnology Award

UCSF bioengineer Tejal Desai, PhD, will receive the 2012 Paul R. Dawson Biotechnology Award from the American Association of Colleges of Pharmacy (AACP) at the group’s annual meeting in July.

Artificial kidney project led by Roy chosen for accelerated FDA program

The effort led by UCSF bioengineer Shuvo Roy, PhD, to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the U.S. Food and Drug Administration (FDA).

Shoichet is the new director of the QB3 at UCSF

Computational chemist Brian Shoichet, PhD, a faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, is the new director of the California Institute for Quantitative Biosciences

Pages